3e62: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3e62.png|left|200px]] | [[Image:3e62.png|left|200px]] | ||
Line 18: | Line 17: | ||
--> | --> | ||
{{ABSTRACT_PUBMED_19019674}} | {{ABSTRACT_PUBMED_19019674}} | ||
==About this Structure== | ==About this Structure== | ||
[[3e62]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3E62 OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019019674</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
[[Category: Antonysamy, S.]] | |||
[[Category: Hirst, G.]] | |||
[[Category: Park, F.]] | [[Category: Park, F.]] | ||
[[Category: Sprengeler, P.]] | |||
[[Category: Stappenbeck, F.]] | |||
[[Category: Steensma, R.]] | |||
[[Category: Thompson, D A.]] | |||
[[Category: Wilson, M.]] | |||
[[Category: Wong, M.]] | |||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Disease mutation]] | [[Category: Disease mutation]] | ||
[[Category: Drug discovery]] | [[Category: Drug discovery]] | ||
Line 40: | Line 43: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
[[Category: Proto-oncogene]] | [[Category: Proto-oncogene]] | ||
[[Category: Sh2 domain]] | [[Category: Sh2 domain]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
Revision as of 09:25, 1 February 2012
Fragment based discovery of JAK-2 inhibitorsFragment based discovery of JAK-2 inhibitors
Template:ABSTRACT PUBMED 19019674
About this StructureAbout this Structure
3e62 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Antonysamy S, Hirst G, Park F, Sprengeler P, Stappenbeck F, Steensma R, Wilson M, Wong M. Fragment-based discovery of JAK-2 inhibitors. Bioorg Med Chem Lett. 2009 Jan 1;19(1):279-82. Epub 2008 Aug 22. PMID:19019674 doi:10.1016/j.bmcl.2008.08.064
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Non-specific protein-tyrosine kinase
- Antonysamy, S.
- Hirst, G.
- Park, F.
- Sprengeler, P.
- Stappenbeck, F.
- Steensma, R.
- Thompson, D A.
- Wilson, M.
- Wong, M.
- Atp-binding
- Disease mutation
- Drug discovery
- Fragment based
- Jak2
- Kinase
- Membrane
- Nucleotide-binding
- Phosphoprotein
- Proto-oncogene
- Sh2 domain
- Transferase
- Tyrosine-protein kinase